Inventor · disambiguated record
Ashwin U. Rao
Also filed as: RAO ASHWIN · RAO ASHWIN U · RAO ASHWIN UMESH
19 granted patents·7 pending applications·68 citations·filing 2005–2024
92Inventor score
Top patents by PatentIndex Score
26 records- 0192US7709641B2NK1 antagonistsOPKO HEALTH INC·Filed 2005·Granted May 4, 2010·20 cites·30 claims
- 0289US8026364B2NK1 antagonistsOPKO HEALTH INC·Filed 2010·Granted Sep 27, 2011·11 cites·39 claims
- 0384US8754216B2NK1 antagonistsSHAH SAPNA S·Filed 2011·Granted Jun 17, 2014·9 cites·38 claims
- 0479US7723342B2Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemiaSCHERING CORP·Filed 2006·Granted May 25, 2010·4 cites·61 claims
- 0579US7354922B2Bridged ring NK1 antagonistsSCHERING CORP·Filed 2005·Granted Apr 8, 2008·4 cites·30 claims
- 0678US9469629B2NK1 antagonistsOPKO HEALTH INC·Filed 2014·Granted Oct 18, 2016·2 cites·12 claims
- 0778US8927559B2Quinazolinone-type compounds as CRTH2 antagonistsASLANIAN ROBERT G·Filed 2011·Granted Jan 6, 2015·6 cites·16 claims
- 0878US7737155B2Nitrogen-containing heterocyclic compounds and methods of use thereofSCHERING CORP·Filed 2007·Granted Jun 15, 2010·2 cites·35 claims
- 0974US7750015B2Nitrogen-containing heterocyclic compounds and methods of use thereofSCHERING CORP·Filed 2006·Granted Jul 6, 2010·2 cites·47 claims
- 1072US9469615B2Quinoxalines and AZA-quinoxalines as CRTH2 receptor modulatorsBOYCE CHRISTOPHER W·Filed 2011·Granted Oct 18, 2016·4 cites·27 claims
- 1166US8324213B2Biaryl-spiroaminooxazoline analogues as alpha 2C adrenergic receptor modulatorsMCCORMICK KEVIN D·Filed 2009·Granted Dec 4, 2012·1 cites·11 claims
- 1265US8283360B2Bicyclic heterocyclic derivatives and methods of use thereofPALANI ANANDAN·Filed 2009·Granted Oct 9, 2012·1 cites·2 claims
- 1364US2018215729A1Nk 1 antagonistsOPKO HEALTH INC·Filed 2018·Application pending·0 cites
- 1463US8889683B2Substituted quinoxalines as inhibitors of fatty acid binding proteinCHENG CLIFFORD·Filed 2011·Granted Nov 18, 2014·2 cites·9 claims
- 1563US2024287138A1Cyclic peptides for inhibiting tnf receptor 1 activityMERCK SHARP & DOHME LLC·Filed 2024·Application pending·0 cites
- 1662US9969711B2NK1 antagonistsOPKO HEALTH INC·Filed 2016·Granted May 15, 2018·0 cites·6 claims
- 1760US2025026762A1Fused pyrazole urea analogs as glucosylceramide synthase inhibitorsMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 1855US8569312B2Biaryl-spiroaminooxzaoline analogues as alpha 2C adrenergic receptor modulatorsMERCK SHARP & DOHME·Filed 2013·Granted Oct 29, 2013·0 cites·11 claims
- 1954US8476274B2Biaryl spiroaminooxazoline analogues as Alpha2C adrenergic receptor modulatorsMERCK SHARP & DOHME·Filed 2012·Granted Jul 2, 2013·0 cites·10 claims
- 2048US2010227873A1Nitrogen-containing heterocyclic compounds and methods of use thereofSCHERING CORP·Filed 2010·Application pending·0 cites
- 2144US9290454B2Substituted isoquinolines as CRTH2 receptor modulatorsMERCK SHARP & DOHME·Filed 2013·Granted Mar 22, 2016·0 cites·19 claims
- 2244US2011152259A1Nitrogen-containing heterocyclic compounds and methods of use thereofPALANI ANANDAN·Filed 2011·Application pending·0 cites
- 2340US10875851B2Factor XIIa inhibitorsMERCK SHARP & DOHME·Filed 2017·Granted Dec 29, 2020·0 cites·13 claims
- 2438US10414775B2Compounds useful for altering the levels of bile acids for the treatment of diabetes and cardiometabolic diseaseMERCK SHARP & DOHME·Filed 2017·Granted Sep 17, 2019·0 cites·18 claims
- 2538US2012225885A1Imidazole derivatives and methods of use thereofRAO ASHWIN U·Filed 2010·Application pending·0 cites
- 2630US2011207734A1Azine Derivatives and Methods of Use ThereofPALANI ANANDAN·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →